J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event
Prepared Statement by J. Craig Venter, Ph.D. It is gratifying to see that the Obama Administration realizes the gr...
Human Longevity, Inc. Signs Agreement with Genentech for Whole Genome Sequencing and Analysis of Samples
(LA JOLLA, CA) January 14, 2015—Human Longevity, Inc. (HLI), the human health information technology and health c...
- Celera reunion at AGBT meeting in Florida http://t.co/iV0DD5STr1 #AGBT15
[7 hours ago]
- President @BarackObama speaking on Precision Medicine Initiative from @WhiteHouse #Genomics http://t.co/hubryUoO9C
[4 weeks ago]
- .@JCVenter, Co-Founder and CEO, @humanlongevity (HLI) Participates in @WhiteHouse Precision Medicine Event http://t.co/4KrMdqUNZD #genomics
[4 weeks ago]
- .@HumanLongevity Signs Agreement with @Genentech for Whole Genome Sequencing and Analysis of Samples http://t.co/2reZpvFtS4 #genomics
[1 month ago]
Using the combined power of our core areas of expertise—genomics, informatics, and stem cell therapies, we are tackling one of the greatest medical/scientific and societal challenges—aging and aging related diseases. –Dr. J. Craig Venter
The global market for healthy human longevity is enormous with total healthcare expenditures in those 65 and older running well over $7 trillion. We believe that HLI’s unique science and technology, along with our business leadership, will positively impact the healthcare market with novel diagnostics and therapeutics. –Dr. Robert Hariri
HLI is going to change the way medicine is practiced by helping to shift to a more preventive, genomic-based medicine model which we believe will lower healthcare costs. Our goal is not necessarily lengthening life, but extending a healthier, high performing, more productive life span. –Dr. J. Craig Venter
Between 1910 and 2010 improvements in medicine and sanitation increased the human lifespan by 50 percent from 50 to 75 years. Today with the emergence of exponential technologies such as those being pioneered and advanced by HLI we have the potential to meaningfully extend the lifespan even further. –Dr. Peter H. Diamandis